GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carbiotix AB (XSAT:CRBX) » Definitions » Gross Margin %

Carbiotix AB (XSAT:CRBX) Gross Margin % : 425.23% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Carbiotix AB Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Carbiotix AB's Gross Profit for the three months ended in Dec. 2024 was kr0.47 Mil. Carbiotix AB's Revenue for the three months ended in Dec. 2024 was kr0.11 Mil. Therefore, Carbiotix AB's Gross Margin % for the quarter that ended in Dec. 2024 was 425.23%.

Warning Sign:

Carbiotix AB gross margin has been in long-term decline. The average rate of decline per year is -41.5%.


The historical rank and industry rank for Carbiotix AB's Gross Margin % or its related term are showing as below:

XSAT:CRBX' s Gross Margin % Range Over the Past 10 Years
Min: 110.68   Med: 384   Max: 2751.54
Current: 177.84


During the past 8 years, the highest Gross Margin % of Carbiotix AB was 2751.54%. The lowest was 110.68%. And the median was 384.00%.

XSAT:CRBX's Gross Margin % is ranked better than
99.38% of 809 companies
in the Medical Devices & Instruments industry
Industry Median: 53.01 vs XSAT:CRBX: 177.84

Carbiotix AB had a gross margin of 425.23% for the quarter that ended in Dec. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Carbiotix AB was -41.50% per year.


Carbiotix AB Gross Margin % Historical Data

The historical data trend for Carbiotix AB's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carbiotix AB Gross Margin % Chart

Carbiotix AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Margin %
Get a 7-Day Free Trial 2,751.54 629.93 532.60 235.40 177.83

Carbiotix AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 195.97 142.67 -28.81 509.89 425.23

Competitive Comparison of Carbiotix AB's Gross Margin %

For the Medical Devices subindustry, Carbiotix AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carbiotix AB's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carbiotix AB's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Carbiotix AB's Gross Margin % falls into.


;
;

Carbiotix AB Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Carbiotix AB's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as

Gross Margin % (A: Dec. 2024 )=Gross Profit (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=1.7 / 0.979
=(Revenue - Cost of Goods Sold) / Revenue
=(0.979 - -0.762) / 0.979
=177.83 %

Carbiotix AB's Gross Margin for the quarter that ended in Dec. 2024 is calculated as


Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=0.5 / 0.111
=(Revenue - Cost of Goods Sold) / Revenue
=(0.111 - -0.361) / 0.111
=425.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Carbiotix AB  (XSAT:CRBX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Carbiotix AB had a gross margin of 425.23% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Carbiotix AB Gross Margin % Related Terms

Thank you for viewing the detailed overview of Carbiotix AB's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Carbiotix AB Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 22, Lund, SWE, 223 63
Carbiotix AB is a Sweden based pre-clinical stage therapeutics company focused on gut health testing and microbiome modulators to address a range of chronic and metabolic diseases. The products of the company include OneGut, MonthGut, LinkGut, and HealthGut.

Carbiotix AB Headlines

No Headlines